Disc Medicine, Inc. (IRON)
NASDAQ: IRON · IEX Real-Time Price · USD
45.40
-0.79 (-1.71%)
At close: Jul 19, 2024, 4:00 PM
45.39
-0.01 (-0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Disc Medicine Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
74
Market Cap
1.35B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 0 | - | - |
| Dec 31, 2022 | 0 | - | - |
| Dec 31, 2021 | 0 | - | - |
| Dec 31, 2020 | 0 | - | - |
| Dec 31, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.25B |
| Indivior | 1.12B |
| U.S. Physical Therapy | 611.97M |
| ANI Pharmaceuticals | 517.46M |
| Phreesia | 373.67M |
| Dynavax Technologies | 236.15M |
| Vir Biotechnology | 79.60M |
| Nurix Therapeutics | 62.30M |
IRON News
- 5 weeks ago - Disc Medicine Announces Underwritten Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress - GlobeNewsWire
- 7 weeks ago - Disc Medicine to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress - GlobeNewsWire
- 2 months ago - Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference - GlobeNewsWire
- 2 months ago - Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - Top 3 Health Care Stocks You'll Regret Missing This Month - Humana (NYSE:HUM), Disc Medicine (NASDAQ:IRON) - Benzinga
- 4 months ago - Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) - GlobeNewsWire